Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

British Journal of Cancer

Volumn 83, Issue 3, 2000, Pages 384-386

  Verhoog, L C ^a   Brekelmans, C T M ^a   Seynaeve, C ^a   Meijers Heijboer, E J ^b   Klijn, J G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

BRCA1

Indexed keywords

BRCA1 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL DECISION MAKING; ONSET AGE; PRIORITY JOURNAL;

EID: 0033949548     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1239     Document Type: Article

References (17)

1. Adami HO, Bergstrom R and Hansen J (1985) Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer 55: 643-647
2. Anderson DE (1971) Some characteristics of familial breast cancer. Cancer 28: 1500-1505
3. Broët P, de la Rochefordière, Scholl SM, Fourquet A, Mosseri V, Durand J-C, Pouillart P and Asselain B (1995) Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 13: 1578-1583
4. Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351: 1451-1467
5. Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56: 265-271
6. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE and the Breast Cancer Linkage Consortium (1994) Risk of cancer in BRCA1 mutation carriers. Lancet 343: 692-695
7. Ford D, Easton DF and Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457-1462
8. Ford D, Easton DF, Stratton M. Narod S. Goldgar D, Devilee P, Bishop T. Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M and the Breast Cancer Linkage Consortium (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62: 676-689
9. Hislop TG, Elwood JM, Coldmann AJ, Spinelli JJ, Worth JJ and Ellison LG (1984) Second primary cancer of the breast: incidence and risk factors. Br J Cancer 49: 70-85
10. Hogervorst FBL, Cornelis RS, Bout M, van Vliet M, Oosterwijk JC, Olmer R, Bakker B, Klijn JGM, Vasen HFA, Meijers-Heijboer H, Menko FH, Cornelisse CJ, den Dunnen JT, Devilee P and van Ommen GJB (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 10: 208-212
11. Newman B, Mu H, Butler LM, Millikan RC, Moorman PG and King MC (1998) Frequency of breast cancer attributable to BRCA in a population-based series of American women. JAMA 279: 915-921
12. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J and Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91: 943-949
13. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R. Drüsedau M, Hogervorst FLB, Hageman S, Arts PJW, Ligtenberg MJL. Meijers-Heijboer H, Klijn JGM, Vasen HFA, Cornelisse CJ, van't Veer LJ, Bakker E, van Ommen GJB and Devilee P (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17: 341-345
14. Prior P and Waterhouse JA (1978) Incidence of bilateral tumours in a population-based series of breast-cancer patients. I. Two approaches to an epidemiological analysis. Br J Cancer 37: 620-634
15. Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, Hirschaut Y, Pressman P, Rosen PP, Lesser ML, Norton L and Offit K (1998) BRCA-associated breast cancer in young women. J Clin Oncol 16: 1642-1649
16. Verhoog LC, Brekelmans CTM, Seynaeve C, van den Bosch LMC, Dahmen G, van Geel AN, Tilanus-Linthorst MMA, Bartels CCM, Wagner A, van den Ouweland A, Devilee P, Meijers-Heijboer EJ and Klijn JGM (1998) Survival and tumour characteristics of breast-cancer patients with germline mutations in BRCA1. Lancet 351: 316-321
17. Verhoog LC, Brekelmans CTM, Seynaeve C, Dahmen G, van Geel AN, Bartels CCM, Tilanus-Linthorst MMA, Wagner A, Devilee P, Halley DJJ, van den Ouweland AMW, Meijers-Heijboer EJ and Klijn JGM (1999) Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol 17: 3396-3402